GAMH
NBP

Greenwoods Asset Management (HK)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Greenwoods Asset Management (HK)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,206
Closed -$880K – 33
2022
Q1 		$880K Buy
+54,206
New +$1.39M 0.04% 33

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Greenwoods Asset Management (HK)'s NBP Position: Q2 2022 in Review

Greenwoods Asset Management (HK) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 54,206 shares — an estimated $880K sold.

Greenwoods Asset Management (HK) first reported a position in NBP in Q1 2022 and held it in 1 quarter. The position peaked at $880K in Q1 2022. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Greenwoods Asset Management (HK) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Greenwoods Asset Management (HK) sold 54,206 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $880K.
  • Greenwoods Asset Management (HK) first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2022 and held it in 1 quarter.
  • Greenwoods Asset Management (HK)'s NovaBridge Biosciences American Depositary Shares position peaked at $880K in Q1 2022.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Greenwoods Asset Management (HK)'s 13F filing for Q2 2022, filed 12 Aug 2022.